Medpace Holdings Inc <MEDP.O>: Mizuho Raises Target Price to $586 From $495
MEDP•Related News
Clearmind Medicine posts update on CMND-100 first-in-human trial webinar insights
CMND•
Gloo plans to use offering proceeds for acquisitions, investments and working capital
GLOO•
Nasdaq trade halt continues NUTR.O reason not available at 09:00 AM
NUTR•
Voyager wins FDA IND clearance for Alzheimer’s gene therapy VY1706
VYGR•
Hormuz traffic slows to two-month low as renewed US, Iran strikes raise safety risk
XLE•